Not presented as a substitution for doctors advice or hospital visit.
Serious wounds need doctor or hospital care.
Bottom Line: Try Neosporin or bacitracin, clean thoroughly.
EVIDENCE-BASED ANSWER
The use of topical triple-antibiotic
ointments significantly decreases infection rates in minor
contaminated wounds compared with a petrolatum control. Plain
petrolatum ointment is equivalent to triple-antibiotic ointments for
sterile wounds as a post-procedure wound dressing (strength of
recommendation [SOR]: A, based on randomized controlled trials [RCTs]).
Mupirocin cream is as effective as oral cephalexin in the
treatment of secondarily infected minor wounds and, because of
better tolerability, is the treatment of choice for the prevention
and treatment of Staphylococcus aureus and Staphylococcus pyogenes
infections. Emerging resistance, including methicillin-resistant S
aureus (MRSA), makes it prudent to check for clinical response in 24
to 48 hours. Major contaminated wounds requiring parenteral
antibiotics do not appear to additionally benefit from topical
antibiotics (SOR: A, based on RCTs).
Most Popular Articles
in Health
Topical antibiotics may also aid in the healing of chronic wounds
(SOR: B, based on a systematic review of low-quality RCTs), as does
the application of honey (SOR: B, based on a systematic review of
cohort studies).
CLINICAL COMMENTARY
It would be helpful to have objective criteria to properly
classify skin wounds These results are encouraging, but they do not
fully account for variability in the diagnosis of skin wounds or in
the practical use of topical agents. The evaluation of skin wounds
is inherently subjective. In order to properly apply these findings
to my practice, it would be helpful to have more objective
diagnostic criteria to properly classify skin wounds.
Furthermore, how patients use topical agents varies considerably.
Patients apply topical agents differently, due to individual
preference or perhaps inconsistent recommendations from their
physician. Used improperly, topical agents may not provide the same
potential for clinical improvement.
Michael Mendoza, MD, MPH
Pritzker School of Medicine, University of Chicago
* Evidence summary
Topical antibiotics for prophylaxis
Numerous studies support the prophylactic application of topical
antibiotics to wounds that are clean. Topical bacitracin zinc (Bacitracin),
a triple ointment of neomycin sulfate, bacitracin zinc, and
polymyxin B sulfate (Neosporin), and silver sulfadiazine (Silvadene)
were compared with petrolatum as a control in a well-conducted RCT
of 426 patients with uncomplicated wounds seen at a military
community hospital. Wound infection rates were 17.6% (19/108) for
petrolatum, 5.5% (6/109) for Bacitracin (number needed to treat [NNT]=8),
4.5% (5/110) for Neosporin (NNT=8), and 12.1% (12/99) for Silvadene
(NNT=18). (1) Most (60%) of the infections were "stitch abscesses"
and were treated with local care only. There was no difference in
rates of more serious infections between groups. One patient (0.9%)
developed a hypersensitivity reaction to Neosporin.
A clinical trial compared the efficacy of a cetrimide, bacitracin
zinc, and polymyxin B sulfate gel (a combination not available in
the US) with placebo and povidone-iodine cream in preventing
infections in 177 minor wounds (cuts, grazes, scrapes, and
scratches) among children. The antibiotic gel was found to be
superior to placebo and equivalent to povidone-iodine, in that it
reduced clinical infections from 12.5% to 1.6% (absolute risk
reduction [ARR]=0.109; 95% confidence interval [CI], 0.011-0.207;
NNT=11). (2)
A double-blind study of 59 patients found Neosporin superior to
placebo ointment in the prevention of streptococcal pyoderma for
children with minor wounds. Infection occurred in 47% of
placebo-treated children compared with 15% treated with the
triple-antibiotic ointment (NNT=32; P=.01). (3)
A small randomized prospective trial of 99 patients, who
self-reported compliance with wound care and dressing changes,
compared Neosporin with mupirocin (Bactroban) in preventing
infections in uncomplicated soft tissue wounds. The study found no
statistical difference in infection rates, and the authors recommend
the more cost-effective Neosporin, as well as a larger trial to
confirm the results. (4)
Another randomized controlled trial of 933 outpatients--with a
total of 1249 wounds from sterile dermatologic surgeries--compared
white petrolatum with bacitracin zinc ointment prophylaxis. The
study found no statistically significant differences in
post-procedure infection rates, though only 13 patients developed an
infection (2% in petrolatum group vs. 0.9% in bacitracin zinc group;
95% CI for the difference, -0.4 to 2.7). (5)
Topical antibiotics for treatment
Topical antimicrobials are appealing for the treatment of
secondarily infected wounds for the sake of convenience and because
they may reduce the risk of adverse effects.
An open randomized trial with 48 volunteers compared the effects
of Neosporin with several antiseptics (3% hydrogen peroxide, 1%
povidone-iodine, 0.25% acetic acid, 0.5% sodium hydrochloride) and a
wound protectant (Johnson & Johnson First Aid Cream without
antimicrobial agent) on blister wounds (6 blisters per volunteer)
intentionally contaminated with S aureus. Only Neosporin eliminated
the infection after 2 applications (at 16 and 24 hours). Both the
antibiotic ointment and the wound protectant led to faster wound
healing by about 4 days compared with the antiseptics or no
treatment. (6)